Priya Raman
Biochemistry Writer
Priya handles mechanism deep dives: receptors, signaling cascades, and why a sequence of amino acids does anything at all. She writes the sections other writers link to when the how question comes up.
Researchers Revisit GLP-1 Drugs and a Rare Eye Condition
A new review in J Endocr Soc examines whether GLP-1 receptor agonists raise the risk of a rare optic nerve condition.
FOXO4-DRI Research Overview: What Studies Show About This Senolytic Peptide
A look at what animal and cell studies show about FOXO4-DRI, a peptide designed to clear senescent cells via the FOXO4 p53 pathway.
FDA Warns Compounding Pharmacy Over Sterility and Potency Failures
FDA warning letter cites Boothwyn Pharmacy for adulterated GLP1 injections, sterility failures, and mislabeled potency.
FDA Opens New Pilot to Speed Up First in Human Drug Trials
FDA's new Expedited IND Pilot pairs drug sponsors with research institutions to speed early trial applications, not to approve any product.
FDA Approves Camizestrant Combo for ESR1 Mutated Breast Cancer
FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1 mutated, HR positive, HER2 negative breast cancer.
CJC-1295 and Ipamorelin: How the Research Pairing Works
CJC-1295 and Ipamorelin are investigational compounds studied together for their combined effect on growth hormone release.
Growth Hormone Peptides: A Complete Guide
A methodical walk through the growth hormone axis: GHRH analogs and ghrelin receptor peptides, and what each one is actually shown to do.